US 10000564
Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10000564 (Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P